FFA
VRTX icon

Fragasso Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Fragasso Financial Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Sell
889
-6
-0.7% -$2.66K 0.02% 233
2026
Q1 		$389K Sell
895
-353
-28% -$165K 0.02% 233
2025
Q4 		$566K Sell
1,248
-9
-0.7% -$3.88K 0.03% 189
2025
Q3 		$507K Buy
1,257
+3
+0.2% +$1.25K 0.03% 192
2025
Q2 		$558K Buy
1,254
+143
+13% +$65.9K 0.04% 176
2025
Q1 		$539K Sell
1,111
-239
-18% -$111K 0.04% 170
2024
Q4 		$544K Sell
1,350
-33
-2% -$15.3K 0.04% 158
2024
Q3 		$643K Buy
1,383
+24
+2% +$11.5K 0.05% 149
2024
Q2 		$637K Buy
1,359
+30
+2% +$13K 0.05% 145
2024
Q1 		$556K Sell
1,329
-600
-31% -$254K 0.05% 152
2023
Q4 		$785K Buy
1,929
+5
+0.3% +$1.85K 0.07% 130
2023
Q3 		$669K Buy
1,924
+8
+0.4% +$2.8K 0.07% 126
2023
Q2 		$674K Buy
1,916
+53
+3% +$17.9K 0.07% 128
2023
Q1 		$587K Buy
+1,863
New +$559K 0.07% 129

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Fragasso Financial Advisors's VRTX Position: Q2 2026 in Review

Fragasso Financial Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 0.67% in Q2 2026, selling an estimated $2.66K and leaving 889 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #233.

Fragasso Financial Advisors first reported a position in VRTX in Q1 2023 and has held it in 14 quarters since. The position peaked at $785K in Q4 2023. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Fragasso Financial Advisors held 889 shares of Vertex Pharmaceuticals worth $442K as of Q2 2026.
  • Fragasso Financial Advisors sold 6 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.66K.
  • Vertex Pharmaceuticals made up 0.02% of Fragasso Financial Advisors's portfolio in Q2 2026, its #233 holding.
  • Fragasso Financial Advisors first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Fragasso Financial Advisors's Vertex Pharmaceuticals position peaked at $785K in Q4 2023.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.